Showing 271-280 of 1752 results for "".
Inflammatory Myopathies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/inflammatory-myopathies/31812/Clinicopathologic classfication can aid understanding and guide treatment.Bruton Tyrosine Kinase Inhibition in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/bruton-tyrosine-kinase-inhibition-in-multiple-sclerosis/31872/The missing link for treatment optimization?Teleneurology for Primary Headache Disorders
https://practicalneurology.com/diseases-diagnoses/headache-pain/teleneurology-for-primary-headache-disorders/31669/During the COVID-19 public health emergency, remote and in-person care for headache disorders is necessary to reduce patient risk.- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0607-movementdisorder-pdf/31164/Sydenham’s Chorea in Adolescents: Clinical Presentation and ManagementSydenham’s chorea is a critical movement disorder in adolescents, often emerging as a delayed neurological complication of acute rheumatic fever (ARF) following a Group A streptococcal infection. While clinicians might first consi
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31385/Optimizing Neurology Practice Management: Insights from Parkinson’s LawNeurology practitioners possess extensive knowledge of neurological disorders such as Parkinson’s disease, yet many remain unaware of Parkinson’s Law, a concept introduced by sociologist C. Northcote Parkinson in the 1950s. Parki
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1005epilepsy-pdf/31388/Exploring the Complex Interplay Between Epilepsy and Mood DisordersEpilepsy and depression frequently coexist as comorbid conditions, significantly impacting patients' quality of life. Comorbidity, defined as the simultaneous occurrence of two or more diseases, does not necessarily indicate causalit
Cannabinoids and Psychedelics for Headache Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-psychedelics-for-headache-management/32131/Reports of success in self-treatment of primary headache disorders with cannabis and psilocybin have led to clinical trials studying their efficacy and safety.Update on Noninvasive Neuromodulation Devices for Headache Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/update-on-noninvasive-neuromodulation-devices-for-headache-treatment/32129/Neuromodulation devices are effective in primary headache management, present low risk, and have minimal to no adverse events but require an understanding of how they can be integrated into the therapeutic armamentarium.Neurologic Assessment & Neuromonitoring in the COVID-19 Pandemic
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-assessment-neuromonitoring-in-the-covid-19-pandemic/31742/Noninvasive monitoring can help triage, monitoring at-risk persons, and assess the need for invasive monitoring modalities.- Remembering Ronald DeVere, MD, FAANhttps://practicalneurology.com/news/remembering-ronald-devere-md-faan/2470936/Ronald DeVere, MD, FAAN, Practical Neurology Editorial Advisory Board member and former Editor of the Dementia Insights column, passed away on May 8, 2024, at age 80. Dr. DeVere served as the Director of the Taste & Smell Disorders Clinic and the Alzheimer Disease & Memory Disorder